These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8357164)

  • 21. A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis.
    Harcourt GC; Sommer N; Rothbard J; Willcox HN; Newsom-Davis J
    J Clin Invest; 1988 Oct; 82(4):1295-300. PubMed ID: 2459161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
    Fujii Y; Lindstrom J
    J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of T-cell reactivity to myasthenogenic epitopes of the human acetylcholine receptor by synthetic analogs.
    Katz-Levy Y; Kirshner SL; Sela M; Mozes E
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7000-4. PubMed ID: 7688469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular anatomy of an autoantigen: T and B epitopes on the nicotinic acetylcholine receptor in myasthenia gravis.
    Manfredi AA; Protti MP; Bellone M; Moiola L; Conti-Tronconi BM
    J Lab Clin Med; 1992 Jul; 120(1):13-21. PubMed ID: 1377215
    [No Abstract]   [Full Text] [Related]  

  • 25. Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the alpha subunit.
    Oshima M; Ashizawa T; Pollack MS; Atassi MZ
    Eur J Immunol; 1990 Dec; 20(12):2563-9. PubMed ID: 2269324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides.
    Atassi MZ; Oshima M
    Crit Rev Immunol; 1997; 17(5-6):481-95. PubMed ID: 9419435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunodominant regions for T helper-cell sensitization on the human nicotinic receptor alpha subunit in myasthenia gravis.
    Protti MP; Manfredi AA; Straub C; Howard JF; Conti-Tronconi BM
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7792-6. PubMed ID: 2145582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactivity of T cells from seronegative patients with myasthenia gravis to T cell epitopes of the human acetylcholine receptor.
    Karni A; Zisman E; Katz-Levy Y; Paas-Rozner M; Dayan M; Brautbar C; Abramsky O; Sela M; Mozes E
    Neurology; 1997 Jun; 48(6):1638-42. PubMed ID: 9191780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of T-cell epitopes of autoantigens using recombinant proteins; studies on experimental autoimmune myasthenia gravis.
    Zhang Y; Frutiger S; Hughes GJ; Savoy MC; Barkas T
    Immunology; 1990 Dec; 71(4):538-43. PubMed ID: 1703986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
    Morell SW; Trinh VB; Gudipati E; Friend A; Page NA; Agius MA; Richman DP; Fairclough RH
    Mol Immunol; 2014 Mar; 58(1):116-31. PubMed ID: 24333757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response of CD4+ T cells from myasthenic patients and healthy subjects of biosynthetic and synthetic sequences of the nicotinic acetylcholine receptor.
    Diethelm-Okita B; Wells GB; Kuryatov A; Okita D; Howard J; Lindstrom JM; Conti-Fine BM
    J Autoimmun; 1998 Apr; 11(2):191-203. PubMed ID: 9650099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.
    Nagvekar N; Moody AM; Moss P; Roxanis I; Curnow J; Beeson D; Pantic N; Newsom-Davis J; Vincent A; Willcox N
    J Clin Invest; 1998 May; 101(10):2268-77. PubMed ID: 9593783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
    Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
    J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complementary strategies to elucidate T helper cell epitopes in myasthenia gravis.
    Jung C; Stoeckle C; Wiesmüller KH; Laub R; Emmrich F; Jung G; Melms A
    J Neuroimmunol; 2008 Sep; 201-202():41-9. PubMed ID: 18649950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice.
    Infante AJ; Levcovitz H; Gordon V; Wall KA; Thompson PA; Krolick KA
    J Immunol; 1992 Jun; 148(11):3385-90. PubMed ID: 1375242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the alpha-subunit.
    Melms A; Malcherek G; Gern U; Wiethölter H; Müller CA; Schoepfer R; Lindstrom J
    Ann Neurol; 1992 Mar; 31(3):311-8. PubMed ID: 1379027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Definition of myasthenogenic sites of the human acetylcholine receptor using synthetic peptides.
    Lennon VA; Griesmann GA; McCormick DJ; Huang ZX; Feng H; Lambert EH
    Ann N Y Acad Sci; 1987; 505():439-50. PubMed ID: 2446556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetylcholine receptor-specific human T-lymphocyte lines.
    Hohlfeld R; Toyka KV; Michels M; Heininger K; Conti-Tronconi B; Tzartos SJ
    Ann N Y Acad Sci; 1987; 505():27-38. PubMed ID: 2446551
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthetic peptide of human acetylcholine receptor alpha-subunit sequence 125-147 (methionine 144), a more potent autoantigen than its norleucine 144 analog.
    Lennon VA; Huang ZX; McCormick DJ; Griesmann GE; Fujii N; Lambert EH
    Ann N Y Acad Sci; 1988; 540():516-9. PubMed ID: 2462827
    [No Abstract]   [Full Text] [Related]  

  • 40. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.